Coherus Oncology, Inc. Common Stock
CHRS
CHRS
137 hedge funds and large institutions have $198M invested in Coherus Oncology, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 38 increasing their positions, 56 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
137
Holders Change
-19
Holders Change %
-12.18%
% of All Funds
1.99%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
23
Increased
38
Reduced
56
Closed
42
Calls
$666K
Puts
$684K
Net Calls
-$18K
Net Calls Change
-$1.97M
Top Buyers
| 1 |
RCMNY
1
Rubric Capital Management (New York)
New York
|
$24.9M |
| 2 |
TC
2
Tejara Capital
London,
United Kingdom
|
$2.52M |
| 3 |
3
Goldman Sachs
New York
|
$4.1M |
| 4 |
CC
4
Clearline Capital
New York
|
$1.87M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$6.55M |
